Composite Map Deposition Guide
Introduction
The deposition of a composite map entry set follows the recommendations laid out by the community in 2020 (https://doi.org/10.48550/arXiv.2311.17640). In accordance with these recommendations we require the composite map, all constituent maps (henceforth referred to as focused refinements), and the un-focused full structure (henceforth known as a consensus map) to be deposited as their own entries so that validation can be carried out for each of the deposited maps. In addition, the composite map entry must appropriately reference the focused refinements and consensus map. In this tutorial we will summarise the workflow to deposit a composite map set of entries in the most efficient manner possible.
In this tutorial we will use publicly available data EMDB: EMD-43299 and PDB: 8VK3.
Graphical Overview
To complete a deposition of a composite map set you will need several maps. These maps are described graphically below and EMD-IDs are included for an example composite map deposition set that can be found on the EMDB website.

Summary
Reminder: A composite map deposition must consist of separate depositions describing the composite map, consensus map, and focused map(s).
- Create a composite map deposition (Do not submit).
- Create focused refinement and consensus depositions (after completing composite map deposition). Pull the metadata from the composite map deposition.
- Associate the focused refinement and consensus depositions to the composite map deposition by filling the IDs in the “related entries” and submit.
Deposition Table
| Composite Map | Consensus Map | Focused Map(s) | |
|---|---|---|---|
| Primary Map |
Required |
Required |
Required |
| Half-maps |
Optional (If provided they must be composite half-maps)* |
Required |
Required |
| Entry Image |
Required |
Required |
Required |
| mmCIF file |
Optional (unless also depositing a model) |
Optional (unless also depositing a model) |
Optional (unless also depositing a model) |
| FSC Curve file |
Optional (If provided it should be calculated from the composite half-maps and described appropriately)** |
Optional |
Optional |
| Mask(s) |
Optional |
Optional |
Optional |
| Additional Map(s) |
Optional |
Optional |
Optional |
| Layer line file |
Not expected |
Not expected |
Not expected |
*If depositing half-maps as part of a composite-map deposition, only composite half-maps should be provided. Consensus and focused half-maps should be provided with the relevant, separate, depositions.
**EMDB recommends using the mean resolution of the focused maps as the resolution of the composite map
Step by Step
-
Start the composite map deposition
We recommend you start by creating the composite map deposition. This entry should contain all the metadata relevant to the other entries and we will be able to copy this across to those entries later. The deposition setup for this can be seen in Figure 1. Don’t forget to sign in with ORCID to enable easy access to all your depositions later on. In this example the model has been built into the composite map, therefore the composite map and model will be deposited together so that map-model validation can be carried out in this entry.

Figure 1: Setting up a composite map deposition.
Once the setup is complete and you have clicked ‘start deposition’ you should receive the details to login to the deposition via email and find it in your ORCID list of depositions if you were signed in with ORCID. The first step is to upload your files, an example of which can be seen in Figure 2, since this is a composite map deposition no half-maps are expected. Don’t forget that the mmCIF file format is also a metadata file format. All metadata provided in the uploaded mmCIF will automatically be used to fill the deposition interface. For users who wish to learn more about mmCIF files the mmCIF dictionary is available online (https://mmcif.wwpdb.org/) and example mmCIF files with EM metadata are available from the EMDB (e.g. https://www.ebi.ac.uk/emdb/EMD-43299?tab=links) under the Metadata section as a cif.gz download.

Figure 2: File upload page for a composite map entry.
After completing this section, the deposition interface will allow all metadata to be entered. Anything that was in the mmCIF file should already be in the deposition interface. Once all metadata sections are filled the entry should look similar to Figure 3.
DO NOT SUBMIT THE DEPOSITION YET!

Figure 3: a completed composite map deposition user-interface
We can now log out of this entry and start the deposition of the other entries.
2. Focused/Consensus map deposition
Now we are going to deposit the focused map(s) and consensus map. There should be one or more focused refinements and one consensus map deposited for every composite map deposited. In this example we will show you the deposition of a single focused refinement map, the method for depositing the others should be identical.
Once again we start by setting up the deposition (Figure 4). This time we will approach it as a regular map deposition (not composite). We have also already deposited coordinates with the composite map, as a result we will deposit the focused refinement(s) and consensus map without a coordinate model. If you have good reason to deposit portions of the model with the focused refinement(s) you are free to do so but where efficiency of deposition is concerned depositing the maps alone will be quicker.

Figure 4: Setting up a deposition for a focused/consensus map
As before, once the deposition is started you will get to the file upload screen. This time you can use the ‘based on a previous wwPDB deposition’ (Figure 5) option during the file upload process. This allows you to copy across various metadata from a previous deposition. Once the file upload is complete you should now see that, where possible, metadata has been transferred to the new deposition (Figure 6). This deposition can now be completed and submitted. Once submitted you will receive an EMD accession code which is needed for the next step.

Figure 5: Copying metadata from the composite map deposition

Figure 6: Metadata pulled from a previous deposition automatically fills relevant pages, in some cases already providing all required information (green tick).
3. Complete the composite map deposition
Now that you have completed all your focused refinement and consensus map depositions we can return to the composite map deposition and associate the new depositions to them. To do this we are going to go to the ‘Related entries’ page and fill the table out. The ‘content type’ drop-down menu will allow you to define the maps as focused or consensus. An example of this can be seen, including how it will be displayed on the EMDB website, in Figure 7. Once this is complete you are ready to submit the composite map deposition. If the composite map is accidentally submitted prematurely, or more entries are generated that you wish to be associated with the composite map after its submission, this can be corrected by contacting a wwPDB biocurator through the communication tab in OneDep.

Figure 7: Filling in the related entries for the composite map deposition.
Recommendation from EMDB: It is advised to use correlated yet distinct titles for entries related to a composite map.
Quick links
Recent Entries
(Show all)Cryo-electron Tomogram of a whole Chlamydia trachomatis elementary body exposed to trifunctional sphingomyelin derivatives (TFSM)
Structure of a glycosylated Vibrio alginolyticus lateral flagellar filament
Cryo-EM structure of DOCK11 complexed with Cdc42(G15A) and Cdc42(Q61L)-GTP in the membrane-bound state
Cryo-EM structure of DOCK11 complexed with Cdc42(G15A) and Cdc42(Q61L)-GTP
Pseudomonas aeruginosa 50S ribosome (L1 stalk in 'mid' conformation)
Structure of mouse RyR1 mutant T4706M (Ca2+/CFF/ATP dataset; open pore)
Structure of mouse RyR1 mutant T4706M (Ca2+/CFF/ATP dataset; closed pore)
Constituent EM map: Focused refinement on S2S3 of mouse RyR1 mutant T4706M (EGTA-only dataset)
Constituent EM map: Focused refinement on TaF+TMD+CTD of mouse RyR1 mutant T4706M (EGTA-only dataset)
Constituent EM map: Focused refinement on JSol+CSol of mouse RyR1 mutant T4706M (EGTA-only dataset)
Constituent EM map: Focused refinement on NTD+SPRY+Calstabin-1 of mouse RyR1 mutant T4706M (EGTA-only dataset)
Constituent EM map: Focused refinement on BSol of mouse RyR1 mutant T4706M (EGTA-only dataset)
Constituent EM map: Focused refinement on Ry12 of mouse RyR1 mutant T4706M (EGTA-only dataset)
Constituent EM map: Focused refinement on Ry34 of mouse RyR1 mutant T4706M (EGTA-only dataset)
Constituent EM map: Focused refinement on NTD+SPRY+Calstabin-1 of mouse RyR1 mutant T4706M (Ca2+/CFF/ATP dataset; closed pore)
Raw consensus map of mouse RyR1 mutant T4706M (Ca2+/CFF/ATP dataset; closed pore)
Constituent EM map: Focused refinement on JSol+CSol of mouse RyR1 mutant T4706M (Ca2+/CFF/ATP dataset; closed pore)
Constituent EM map: Focused refinement on S2S3 of mouse RyR1 mutant T4706M (Ca2+/CFF/ATP dataset; closed pore)
Constituent EM map: Focused refinement on BSol of mouse RyR1 mutant T4706M (Ca2+/CFF/ATP dataset; closed pore)
Constituent EM map: Focused refinement on Ry12 of mouse RyR1 mutant T4706M (Ca2+/CFF/ATP dataset; closed pore)
Constituent EM map: Focused refinement on Ry34 of mouse RyR1 mutant T4706M (Ca2+/CFF/ATP dataset; closed pore)
Constituent EM map: Focused refinement on TaF+TMD+CTD of mouse RyR1 mutant T4706M (Ca2+/CFF/ATP dataset; closed pore)
Constituent EM map: Focused refinement on NTD+SPRY+Calstabin of mouse RyR1 mutant T4706M (Ca2+/CFF/ATP dataset; open pore)
Raw consensus map of mouse RyR1 mutant T4706M (Ca2+/CFF/ATP dataset; open pore)
Constituent EM map: Focused refinement on BSol of mouse RyR1 mutant T4706M (Ca2+/CFF/ATP dataset; open pore)
Constituent EM map: Focused refinement on TaF+TMD+CTD of mouse RyR1 mutant T4706M (Ca2+/CFF/ATP dataset; open pore)
Constituent EM map: Focused refinement on JSol+CSol of mouse RyR1 mutant T4706M (Ca2+/CFF/ATP dataset; open pore)
Constituent EM map: Focused refinement on Ry34 of mouse RyR1 mutant T4706M (Ca2+/CFF/ATP dataset; open pore)
Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus S-nidradine
Constituent EM map: Focused refinement on S2S3 of mouse RyR1 mutant T4706M (Ca2+/CFF/ATP dataset; open pore)
Constituent EM map: Focused refinement on Ry12 of mouse RyR1 mutant T4706M (Ca2+/CFF/ATP dataset; open pore)
Cryo-EM structure of L9-yd19 in complex with Plasmodium falciparum circumsporozoite protein (PfCSP) Kenya2-3 strain
Cryo-EM structure of L9-yd19 in complex with Plasmodium falciparum circumsporozoite protein (PfCSP) 3D7 strain
photosystem I with eight LHCI from a green alga as lichen phycobiont
Cryo-EM structure of CRU4 cruciferin homohexamer, an 11S globulin from Brassica napus
5HT2AR-miniGq heterotrimer in complex with a novel agonist IHCH-8152
photosystem I with two LHCI from a green alga as lichen phycobiont
Cryo-EM structure of Oceanobacillus iheyensis group II intron domains D1-D5
Structural characterization of hibernating ribosomes in the Gram-negative pathogen Pseudomonas aeruginosa
Cryo-EM structure of Oceanobacillus iheyensis group II intron domains D1-D5
CRYO-EM FOCUSED REFINEMENT MAP OF TRYPANOSOMA BRUCEI BLOODSTREAM FORM 80S RIBOSOME : NATIVE VACANT
Cryo-EM structure of Oceanobacillus iheyensis group II intron domains D1-D5
Cryo-EM structure of Oceanobacillus iheyensis group II intron domains D1-D5
CRYO-EM STRUCTURE OF TRYPANOSOMA BRUCEI BLOODSTREAM FORM 80S RIBOSOME : NATIVE VACANT
CRYO-EM CONSENSUS MAP OF TRYPANOSOMA BRUCEI BLOODSTREAM FORM 80S RIBOSOME : NATIVE VACANT
Cryo-EM structure of Oceanobacillus iheyensis group II intron domains D1-D5
Cryo-EM structure of Oceanobacillus iheyensis group II intron domains D1-D5
Mycobacterium tuberculosis gyrase holocomplex with 150 bp DNA and corramycin
Cryo-EM structure of Oceanobacillus iheyensis group II intron domains D1-D5
Hexamer-hexamer interface from purified HIV-1 cores bound to lenacapavir tilt 11.8 twist 2.8
Hexamer-hexamer interface from purified HIV-1 cores bound to lenacapavir tilt 4.4 twist 2.6
Pseudomonas aeruginosa 50S ribosome (L1 stalk in 'out' conformation and missing uL1 and tRNA)
Tail domain of full-length phi-like human dynein-1 bound to dynactin-p150glued and LIS1
CryoEM Structure of Gq-coupled MRGPRX1 in complex with de novo protein mM1_060 (E12)
Consensus map of full-length phi-like human dynein-1 bound to dynactin-p150glued and LIS1
Pseudomonas aeruginosa 50S ribosome (L1 stalk in 'out' conformation)
The ligand free HCoV-HKU1 spike structure obtained from data collected on 100 kV Tundra at 180kX magnification with Falcon C detector
Hexamer-hexamer interface from purified HIV-1 cores bound to lenacapavir tilt 18.4 twist 1.7
Hexamer-hexamer interface from purified HIV-1 cores bound to lenacapavir tilt 7.7 twist -0.9
Hexamer-hexamer interface from purified HIV-1 cores bound to lenacapavir tilt 11.5 twist -3.9
Hexamer-hexamer interface from purified HIV-1 cores bound to lenacapavir tilt 12.0 twist 7.2
Hexamer-hexamer interface from purified HIV-1 cores bound to lenacapavir tilt 11.4 twist -1.6
Hexamer-hexamer interface from purified HIV-1 cores bound to lenacapavir tilt 6.9 twist 2.5
Hexamer-hexamer interface from purified HIV-1 cores bound to lenacapavir tilt 11.8 twist 2.2
Hexamer-hexamer interface from purified HIV-1 cores bound to lenacapavir tilt 11.8 twist 2.5
Hexamer-hexamer interface from purified HIV-1 cores bound to lenacapavir tilt 11.9 twist 5.9
Hexamer-hexamer interface from purified HIV-1 cores bound to lenacapavir tilt 8.5 twist 5.6
Hexamer-hexamer interface from purified HIV-1 cores bound to lenacapavir tilt 15.4 twist 4.6
Human Mfsd2b bound to S1P in outward-facing conformation, digitonin extraction
Hexamer-hexamer interface from purified HIV-1 cores bound to lenacapavir tilt 16.9 twist 1.9
Hexamer-hexamer interface from purified HIV-1 cores bound to lenacapavir tilt 15.5 twist -0.9
Cryo-EM reconstruction of CDK11-cyclin L-SAP30BP in the presence of cryo-tide
Cryo-EM reconstruction of CDK11-cyclin L-SAP30BP without cryo-tide
Dimer of tubulin folding cofactors D and E bound to beta tubulin in the back to back orientation
Dimer of tubulin cofactors D,E, and Arl2 bound to beta tubulin in a back to back orientation
Dimer of tubulin folding cofactors D and E bound to beta tubulin in a side to side orientation
Cryo-EM structure of human IL-10RA and IL-10RB in complex with tandem VHHs E07-A05
Subtomogram Average of the Ribosome-Multipass Translocon-EMC Complex
LPT translocon complex from Flavobacter johnsoniae built in composite volume
LPT translocon complex from Bacteroides thetaiotaomicron - focus volume, membrane and extracellular region
Structure of Fab 04-1D02 in complex with hemagglutinin from influenza A (A/Hawaii/70/2019) H1N1
LPT translocon complex from Bacteroides thetaiotaomicron - consensus volume
LPT translocon complex from Bacteroides thetaiotaomicron - focus volume, periplasmic region
LPT translocon complex from Bacteroides thetaiotaomicron built in composite volume
Structure of Fab 53-1A09 in complex with hemagglutinin from influenza A (A/Solomon Island/3/2006) H1N1
Alpha-Synuclein Type 1A Fibrils at pH 7.0 (co-existing with 1/7, 2A and 5A fibrils in Sample 45)
Polyclonal immune complex comprising SARS-CoV-2 spike (BA.2.87.1) and a class 1 RBD-Down-targeting antibody - Obtained by negative stain EM
Alpha-Synuclein Type 1A Fibrils at pH 7.4 (layer-traversing variant) formed by an N-terminal truncation comprising residues 5-140
Alpha-Synuclein Type 2A Fibrils at pH 7.0 (co-existing with 2B, 5A and 5B fibrils in Sample 23)
Polyclonal immune complex comprising SARS-CoV-2 spike (Wuhan) and a class 1 RBD-Down-targeting antibody - Obtained by negative stain EM
Alpha-Synuclein Type 5A Fibrils. Helical reconstruction with ambiguous symmetry (here as C2)
Block-based reconstruction (block D) of the outer capsid and membrane of the ranavirus Frog Virus 3
Alpha-Synuclein Type 5A Fibrils at pH 7.0 (co-existing with 2A, 2B and 5B fibrils in Sample 23)
Alpha-Synuclein Type 1/7 Fibrils at pH 7.0 (co-existing with 1A, 2A and 5A fibrils in Sample 45)
Alpha-Synuclein Type 5B Fibrils at pH 7.0 (co-existing with 2A, 2B and 5A fibrils in Sample 23)
Alpha-Synuclein Type 1A Fibrils at pH 7.4 (variant 2 of 2 in same sample)
Alpha-Synuclein Type 2B Fibrils at pH 7.0 (co-existing with 2A, 5A and 5B fibrils in Sample 23)
Alpha-Synuclein Type 2A Fibrils at pH 7.0 (co-existing with 1A, 1/7 and 5A fibrils in Sample 45)
Alpha-Synuclein Type 2A(-NS) Fibrils at pH 7.0 formed by a 1:1 mixture of full-length protein and residues 5-140.
Polyclonal immune complex comprising SARS-CoV-2 spike (BA.2.87.1) and a class 1 RBD-Up-targeting antibody - Obtained by negative stain EM
Alpha-Synuclein Type 5A Fibrils at pH 7.0 with 2-start helical symmetry (co-existing with 1A, 1/7 and 2A fibrils in Sample 45)
Alpha-Synuclein Type 8/9 Fibrils at pH 7.0 formed by an N-terminal truncation comprising residues 5-140.
Alpha-Synuclein Type 1A Fibrils at pH 7.4 formed by a 1:1 mixture of full-length protein and residues 5-140 (2.1 Angstrom FSC resolution with choppy density)
Alpha-Synuclein Type 1m Fibrils at pH 7.4 formed by a 19:1 mixture of full-length protein and residues 5-140 (co-existing with 1D in sample 60)
Polyclonal immune complex comprising SARS-CoV-2 spike (Wuhan) and a class 1 NTD-targeting antibody - Obtained by negative stain EM
Alpha-Synuclein Type 6B Fibrils at pH 7.4 formed under strong agitation (coexisting with 6m and 2A in sample 44)
Alpha-Synuclein Type 1/7 Fibrils at pH 7.0 formed by a 1:1 mixture of full-length protein and residues 5-140.
Polyclonal immune complex comprising SARS-CoV-2 spike (Wuhan) and a class 2 NTD-targeting antibody - Obtained by negative stain EM
Polyclonal immune complex comprising SARS-CoV-2 spike (Wuhan) and a class 1 RBD-Up-targeting antibody - Obtained by negative stain EM
Consensus map for full icosahedral reconstruction of the ranavirus Frog virus 3
Polyclonal immune complex comprising SARS-CoV-2 spike (BA.2.87.1) and a class 3 RBD-Up-targeting antibody - Obtained by negative stain EM
Polyclonal immune complex comprising SARS-CoV-2 spike (BA.2.87.1) and a class 2 RBD-Up-targeting antibody - Obtained by negative stain EM
Polyclonal immune complex comprising SARS-CoV-2 spike (Wuhan) and a class 2 RBD-Up-targeting antibody - Obtained by negative stain EM
Block-based reconstruction (block A) of the outer capsid and membrane of the ranavirus Frog Virus 3
Block-based reconstruction (block C) of the outer capsid and membrane of the ranavirus Frog Virus 3
Alpha-Synuclein Type 1D Fibrils at pH 7.4 formed by a 19:1 mixture of full-length protein and residues 5-140 (coexisting with 1m in sample 60)
Alpha-Synuclein Type 6m Fibrils at pH 7.4 formed under strong agitation (coexisting with 6B and 2A in sample 44)
Full-length MICAL1 in the oxidized and autoinhibited state vitrified in the presence of NADPH
Photosystem II from Arabidopsis thaliana following high light and high temperature treatment
Alpha-Synuclein Type 1A Fibrils at pH 7.0 formed by a 19:1 mixture of full-length protein and residues 5-140.
Alpha-Synuclein Type 5A Fibrils. Helical reconstruction with ambiguous symmetry (here as C1)
Alpha-Synuclein Type 1A Fibrils at pH 7.4 (variant 1 of 2 in same sample)
Alpha-Synuclein Type 5A Fibrils. Helical reconstruction with ambiguous symmetry (here as 2-start C1)
Block-based reconstruction (block B) of the outer capsid and membrane of the ranavirus Frog Virus 3
Alpha-Synuclein Type 2B(-NS) Fibrils at pH 7.0 formed by an N-terminal truncation comprising residues 5-140.
Alpha-Synuclein Type 3C Fibrils at pH 5.8 with 2-start helical symmetry
1-protofilament map of taxol stabilized human microtubule using CsMT workflow
2-protofilament heterotypic (seam) map of taxol stabilized human microtubule using CsMT workflow
2-protofilament homotypic map of of taxol stabilized human microtubule using CsMT workflow
1-protofilament map of KIF5A decorated microtubule using CsMT workflow
Cryo-electron Tomogram of a whole Chlamydia trachomatis elementary body
Cryo-electron Tomogram of a FIB milled Chlamydia trachomatis elementary body
Cryo-electron Tomogram of a FIB milled Chlamydia trachomatis elementary body
